Baupost Group BMY trades
Seth Klarman
Seth Klarman Bristol-Myers Squibb Company stake
total: 272
Trades details
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 2
- Held since:
- 2019 Q1
- Held for:
- 4 quarters
- Latest activity:
- 2020 Q1
According to 2026 Q2 report, Seth Klarman doesn't hold any Bristol-Myers Squibb Company (BMY) shares. To date, the estimated cost basis is nearly $46.08 for "buy" trades and estimated average "sell" price is $61.08. Baupost Group first purchased BMY in 2019 Q1, initially acquiring about 4.00M shares. Since the initial investment in Bristol-Myers Squibb Company (BMY), Baupost Group has made 4 more transactions.
When did Seth Klarman sell Bristol-Myers Squibb Company (BMY)?
Seth Klarman sold off the entire Bristol-Myers Squibb Company (BMY) position in 2020 Q1.
When did Seth Klarman buy Bristol-Myers Squibb Company (BMY)?
Seth Klarman first invested in Bristol-Myers Squibb Company (BMY) in 2019 Q1 at the reported quarter-end price of $47.71 per share.
What's the cost basis of Baupost Group's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $46.08 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $46.08
- Weighted AVG sell price:
- $61.08
Seth Klarman's historical trades in Bristol-Myers Squibb Company
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q1
|
0.00%
|
$64.19
|
-100% (-4,000,000)
|
|||
|
2019 Q4
|
2.84%
|
$64.19
|
-60.00% (-6,000,000)
|
|||
|
2019 Q3
|
5.74%
|
$50.71
|
-23.08% (-3,000,000)
|
|||
|
2019 Q2
|
5.34%
|
$45.35
|
+225.00% (+9,000,000)
|
|||
|
2019 Q1
|
1.60%
|
$47.71
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.